Business Description
Stemtech Corp
NAICS : 325411
SIC : 2834
ISIN : US85859W1027
Share Class Description:
STEK: Ordinary SharesDescription
Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | -1.43 | |||||
| Debt-to-Equity | -0.78 | |||||
| Debt-to-EBITDA | -1.33 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.17 | |||||
| Beneish M-Score | -7.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -22.3 | |||||
| 3-Year EPS without NRI Growth Rate | -70.5 | |||||
| 3-Year FCF Growth Rate | -44.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.41 | |||||
| 9-Day RSI | 36.68 | |||||
| 14-Day RSI | 41.16 | |||||
| 3-1 Month Momentum % | -11 | |||||
| 6-1 Month Momentum % | 5.95 | |||||
| 12-1 Month Momentum % | 56.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 24.83 | |||||
| Days Sales Outstanding | 10.99 | |||||
| Days Payable | 1124.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -44.3 | |||||
| Shareholder Yield % | -35.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.94 | |||||
| Operating Margin % | -75.37 | |||||
| Net Margin % | -102.63 | |||||
| FCF Margin % | -13.99 | |||||
| ROA % | -139.48 | |||||
| ROIC % | -53.52 | |||||
| 3-Year ROIIC % | -161.63 | |||||
| ROC (Joel Greenblatt) % | -4593.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.83 | |||||
| EV-to-EBIT | -2.38 | |||||
| EV-to-EBITDA | -2.82 | |||||
| EV-to-Revenue | 1.69 | |||||
| EV-to-FCF | -11.66 | |||||
| Price-to-GF-Value | 0.81 | |||||
| Earnings Yield (Greenblatt) % | -42.02 | |||||
| FCF Yield % | -13.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:STEK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stemtech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.103 | ||
| EPS (TTM) ($) | -0.06 | ||
| Beta | 1.56 | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 209.11 | ||
| 14-Day RSI | 41.16 | ||
| 14-Day ATR ($) | 0.003621 | ||
| 20-Day SMA ($) | 0.040529 | ||
| 12-1 Month Momentum % | 56.14 | ||
| 52-Week Range ($) | 0.0101 - 0.1029 | ||
| Shares Outstanding (Mil) | 134.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stemtech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stemtech Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stemtech Corp Frequently Asked Questions
What is Stemtech Corp(STEK)'s stock price today?
The current price of STEK is $0.04. The 52 week high of STEK is $0.10 and 52 week low is $0.01.
When is next earnings date of Stemtech Corp(STEK)?
The next earnings date of Stemtech Corp(STEK) is .
Does Stemtech Corp(STEK) pay dividends? If so, how much?
Stemtech Corp(STEK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers